USANA Receives Seal of Approval for Joint Health Supplement
"Receiving this third-party seal of approval from ConsumerLab.com shows our customers that we truly care about the quality of our products," says Dan Macuga, USANA's chief communications officer. "USANA continues to create products that are proven to have accurate and truthful labels. I am very proud to be part of a company that works so hard to produce only the best supplements on the market."
ConsumerLab.com is an independent assessor of the quality, purity and label accuracy of health and wellness products, putting each item through rigorous testing. To be awarded a seal of approval from ConsumerLab.com, USANA's Procosa supplement had to contain 100 percent of the claimed amount of glucosamine used to keep joints and cartilage strong and healthy, and to meet quality levels set for lead, arsenic, cadmium, and mercury.
"We take a lot of pride in the supplements we create, so receiving accreditation from an independent organization such as ConsumerLab.com validates what we do here," says USANA's executive director of product development and technology, Dr. John Cuomo. "Procosa is USANA's feature joint-health supplement containing glucosamine, vitamin C and Meriva® bioavailable curcumin complex to help sustain joint and cartilage fitness."
Along with Procosa, several other USANA supplements have been recently certified by ConsumerLab.com, including Visionex, CoQuinone 30, Active Calcium, Vitamin D, Pure Rest, USANA® Probiotic, USANA® Essentials™, Usanimals, BabyCare Prenatal Essentials and Body Rox.
More USANA news
USANA Q3 Net Sales Fall 4% to $206 Million as Core Customers Slide; Company Trims 2026 Outlook
SALT LAKE CITY, Utah - November 3, 2026 USANA Health Sciences reported third-quarter 2026 net sales of $206 million on November 3, down 4 percent from $214 million a year earlier...
USANA Reports Second Quarter Sales of 223 Million Dollars and Net Loss on Impairment
SALT LAKE CITY, Utah -- August 4, 2026 USANA Health Sciences reported second-quarter 2026 net sales of 223 million dollars, down 5% from 236 million dollars a year earlier. The...
USANA Reports Flat First Quarter Net Sales of 250 Million Dollars
SALT LAKE CITY, Utah -- May 5, 2026 USANA Health Sciences reported fiscal first-quarter 2026 net sales of 250 million dollars, unchanged from the year-earlier quarter, as growth...
USANA Swings to Fourth-Quarter Loss as Active Customers Fall to 387,000
SALT LAKE CITY, Utah -- February 17, 2026 USANA Health Sciences reported fourth-quarter 2025 net sales of 226.2 million dollars, up 6 percent from 213.6 million dollars a year...
USANA Chief Executive Jim Brown Steps Down; Kevin Guest Returns as CEO
SALT LAKE CITY, Utah -- January 8, 2026 USANA Health Sciences said Jim Brown has stepped down as chief executive officer and president and that Kevin Guest, the company's...